- Poster presentation
- Open Access
Distribution of pathogens of nosocmial infections in a tertiary-level teaching hospital in Brazil
© Santos et al; licensee BioMed Central Ltd. 2011
- Published: 29 June 2011
- Staphylococcus Aureus
- Pseudomonas Aeruginosa
- Nosocomial Infection
The aim of this study was to describe the distribution of pathogens of nosocomial infections (NI) notified in a tertiary hospital of infectious diseases during 2010.
From January to December 2010, all patients notified with NI according to CDC criteria definitions with agents isolated in cultures were enrolled.
In 2010 were identified 269 pathogens in 409 NI. The distribution including all sites of infection was: Coagulase Negative Staphylococcus (CNS) 20,6%, Pseudomonas aeruginosa 15,9%, Staphylococcus aureus 15,9%, Candida sp 7,8%, Escherichia coli 7,8%, Klebsiella sp 7,8%, Enterococcus sp 5,7%, Enterobacter sp 5,4%, Acinetobacter baumanii 3,4% and other agents 9,7%. The Staphylococcus sp sensibility to oxacilin were: 3,3% to CNS and S. aureus 29,7%; among P. aeruginosa, the sensibility to ceftazidima, cefepima, piperacilin-tazobactam, imipenem, meropenem and ciprofloxacin were, respectively, 64,4%, 62,2%, 59,5%, 72%, 55,5% and 69,5%. The production of ESBL among strains of E.coli and Klebsiella sp were 4,7% and 61,1%, respectively. Among the 175 nosocomial pneumonias notified, only 45 (26%) episodes had pathogens identified. The most important agents identified were P. aeruginosa, S. aureus, CNS and Enterobacter sp; among the bloodstream infection the most prevalent agents were CNS, S. aureus, Klebsiella sp and Candida sp and the most importants agents of urinary tract infections were E. coli, P. aeruginosa, Candida sp, Enterococcus sp and Klebsiella sp.
The commonest agents in our institution were SCN and S. aureus, and P. aeruginosa among the gram negative bacteria. Differently to other tertiary hospitals in Brazil, we found a very low prevalence of Acinetobacter baumanii as agents of NI.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.